Table: Kidswell Bio - 6-MTH group results
Nov 13 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.28 1.75
(+87.2 pct)
Operating 215 mln loss 262 mln
Recurring 76 mln loss 267 mln
Net 60 mln loss 241 mln
EPS 1.26 yen loss 6.09 yen
EPS Diluted 1.23 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T